The microglial phagocytic role with specific plaque types in the Alzheimer disease brain

Neurobiology of Aging

Volumn 25, Issue 5, 2004, Pages 675-683

  D'Andrea, Michael R ^a   Cole, Gregory M ^b   Ard, March D ^c  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid plaques; Astrocytes; Cerebellum; Dense core plaques; Diffuse plaques; Entorhinal cortex; Inflammation; Microglia; Neuropathology; Phagocytosis; Plaque formation; Transgenic mice; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ASTROCYTE; CELL ACTIVATION; HUMAN; MICROGLIA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE;

EID: 2542431100     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.12.026     Document Type: Article

References (73)

1. Ard M.D., Cole G.M., Wei J., Mehrle A.P., Fratkin J.D. Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J. Neurosci. Res. 43:1996;190-202
2. Armstrong R.A., Myers D., Smith C.U.M. The spatial patterns of β/A4 deposit subtypes in Alzheimer's disease. Acta Neuropathol. 86:1993;36-41
3. Bacskai B.J., Kajdasz S.T., Christie R.H., Carter C., Games D., Seubert P., et al. Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat. Med. 7:2001;369-372
4. Bales K.R., Verina T., Ghetti B., Dodel R.C., Du Y., Altstie L., et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat. Genet. 17:1997;263-264
5. Bamberger M.E., Harris M.E., McDonald D.R., Husemann J., Landreth G.E. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 23:2003;2665-2674
6. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6:2000;916-919
7. Chen K., Soriano F., Lyn W., Grajeda H., Masliah E., Games D. Effects of entorhinal cortex lesions on hippocampal β-amyloid deposition in PDAPP transgenic mice. Soc. Neurosci. 24(#92.6):1998;1502
8. Cole G.M., Ard M.D. Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein. Microsc. Res. Technol. 50:2000;316-324
9. Coraci I.S., Husemann J., Berman J.W., Hulette C., Dufour J.H., Campanella G.K., et al. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am. J. Pathol. 160:2002;101-112
10. Cui Y., Le Y., Yazawa H., Gong W., Wang J.M. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J. Leukoc. Biol. 72:2002;628-635
11. D'Andrea M.R. Do plaques in Alzheimer's disease brains have similar origins and fates? Soc. Neurosci. 26(#328.11):2002;55
12. D'Andrea M.R., Nagele R.G. MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in Alzheimer's disease brains. Biotech. Histochem. 77(2):2002;95-103
13. D'Andrea M.R., Nagele R., Lee D.H.S., Wang H.-Y. Targeting intracellular Aβ for Alzheimer's disease drug discovery. Drug Dev. Res. 56:2002;194-200
14. D'Andrea M.R., Nagele R.G., Wang H.-Y., Lee D.H.S. Epitope recovery immunohistochemical methods insure intracellular localization of Aβ42 within Alzheimer's disease pyramidal neurons. Neurosci. Lett. 333(3):2002;163-166
15. D'Andrea M.R., Nagele R.G., Wang H.-Y., Peterson P.A., Lee D.H.S. Evidence that neurons accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology. 38(2):2001;120-134
16. D'Andrea M.R., Reiser P.A., Gumula N.A., Hertzog B.M., Andrade-Gordon P. Application of triple-label immunohistochemistry to characterize inflammation in Alzheimer's disease brains. Biotech. Histochem. 76(2):2001;97-106
17. D'Andrea M.R., Reiser P.A., Polkovitch D.A., Gumula N.A., Belkowski S., Branchide B., et al. The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations. Neurosci. Lett. 342(2):2003;114-118
18. DeLeo J., Toth L., Schubert P., Rudophi K., Kreutzberg G.W. Ischemia-induced neuronal cell death, calcium accumulation, and glial response in the hippocampus of the Mongolian gerbil and protection by propentofylline (HWA 285). J. Cereb. Blood Flow. 7:1987;745-751
19. DeWitt D.A., Perry G., Cohen M., Doller C., Silver J. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 149:1998;329-340
20. DiCarlo G., Wilcock D., Henderson D., Gordon M., Morgan D. Intrahippocampal LPS injections reduce Abeta load in APP + PS1 transgenic mice. Neurobiol. Aging. 22:2001;1007-1012
21. Dickson D.W. The pathogensis of senile plaques. J. Neuropathol. Exp. Path. 56(4):1997;321-339
22. Dickson D.W. Microglia in Alzheimer's disease and transgenic models. How close the fit? Am. J. Pathol. 154(6):1999;1627-1631
23. Dubyak G.R., El-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Phys. 265(3 Pt.1):1993;C577-C606
24. Frautschy S.A., Yang F., Irizarry M., Hyman B., Saido T.C., Hsiao K., et al. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152:1998;307-317
25. Gatan E., Overmier B.J. Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli. Neurosci. Biobehav. Rev. 23:1999;615-633
26. Hock C., Konietzko U., Streffer J.R., Tracy J., Signorell A., Muller-Tillmanns B., et al. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron. 38:2003;547-554
27. i/o-coupled P2Y receptors. J. Neurosci. 21(6):2001;1975-1982
28. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science. 274:1996;99-102
29. sw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56:1997;965-973
30. Itagaki S., McGeer P.L., Akiyama H., Zhu S., Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24:1989;173-182
31. Jantzen P.T., Connor K.E., DiCarlo G., Wenk G.L., Wallace J.L., Rojiani A.M., et al. Microglial activation and β-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J. Neurosci. 22(6):2002;2246-2254
32. Kalaria R.N., Cohen D.L., Premkumar D.R.D. Cellular aspects of the inflammatory response in Alzheimer's disease. Neurodegeneration. 5:1996;497-503
33. Kruetzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19(8):1996;312-318
34. Lemere C.A., Blusztajn J.K., Yamaguchi H., Wisniewski T., Saido T., Selkoe D. Sequence of deposition of heterogeneous amyloid beta-peptides and Apo E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol. Dis. 3:1996;26-32
35. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21:2001;8370-8377
36. Lim G.P., Yang F., Chu T., Chen P., Beech W., Teter B., et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's Disease. J. Neurosci. 20(15):2000;5709-5714
37. Lue L.F., Walker D.G., Rogers J. Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures. Neurobiol. Aging. 22:2001;945-956
38. Mackenzie I.A., Hao C., Munoz D.G. Role of microglia in senile plaque formation. Neurobiol. Aging. 16(5):1995;797-804
39. McDonald D.R., Brunden K.R., Landreth G.E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17:1997;2284-2294
40. McGeer P.L., Klegeris A., Walker D.G., Yasuhara O., McGeer E.G. Pathological proteins in senile plaques. Tohoku J. Exp. Med. 174:1994;269-277
41. Meda L., Baron P., Scarlato G. Glial activation in Alzheimer's disease: the role of Aβ and its associated proteins. Neurobiol. Aging. 22:2001;885-893
42. Moore K.J., El Khoury J., Medeiros L.A., Terada K., Geula C., Luster A.D., et al. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J. Biol. Chem. 277:2002;47373-47379
43. Motte J., Williams R.S. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathol. 77:1989;535-546
44. Miyakawa T., Shimoji A., Kuramoto R., Higuchi Y. The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Virchows Archiv. 40:1982;121-129
45. Mucke L., Yu G.Q., McConlogue L., Rockenstein E.M., Abraham C.R., Masliah E. Astroglial expression of human alpha(1)-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice. Am. J. Pathol. 157:2000;2003-2010
46. Nagele R.G., D'Andrea M.R., Lee H., Venkataraman V., Wang H.-Y. Evidence for glial amyloid plaques in Alzheimer's disease. Brain Res. 971(2):2003;197-209
47. Neary J.T., Rathbone M.P., Cattabeni F., Abbracchio M.P., Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends in Neurosci. 19(1):1996;13-18
48. Nicoll J.A., Wilkinson D., Holmes C., Steart P., Markham H., Weller R.O. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat. Med. 9:2003;448-452
49. Nilsson L.N., Bales K.R., DiCarlo G., Gordon M.N., Morgan D., Paul S.M., et al. Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 21:2001;1444-1451
50. Paresce D.M., Ghosh R.N., Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron. 17:1996;553-565
51. Pluta R., Barcikowska M., Misicka A., Lipkowski A.W., Spisaska S., Januszewski S. Ischemic rats as a model in the study of the neurobiological role of human β-amyloid peptide. Time-dependent disappearing diffuse amyloid plaques in brain. Neurol. Report. 10:1999;3615-3619
52. Raivich G., Moreno-Flores M.T., Möller J.C., Kreutzberg G.W. Inhibition of posttraumatic microglial proliferation in a genetic model of macrophage colony-stimulating factor deficiency in the mouse. Eur. J. Neurosci. 6:1994;1615-1618
53. Rogers J., Strohmeyer R., Kovelowski C.J., Li R. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia. 40:2002;260-269
54. Shaffer L.M., Dority M.D., Gupta-Bansal R., Frederickson R.C., Younkin S.G., Brunden K.R. Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol. Aging. 16(5):1995;737-745
55. Schubert P., Ogata T., Marchini C., Ferroni S. Glia-related pathomechanisms in Alzheimer's disease: a therapeutic target? Mech. Aging Dev. 123:2001;47-57
56. Shen Y., Li R., McGeer E.G., McGeer P.L. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res. 769(2):1997;391-395
57. Sommer B., Sturchler-Pierrat C., Abramowski D., Wiederhold K.H., Calhoun M., Jucker M., et al. Transgenic approaches to model Alzheimer's disease. Rev. Neurosci. 11:2000;47-51
58. Stadler M., Phinney A., Probst A., Sommer B., Staufenbiel M., Jucker M. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am. J. Pathol. 154(6):1999;1673-1684
59. Stoll G., Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 58:1999;233-247
60. Strurchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.-H., Mistl C., Rothacher S., et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U.S.A. 94:1997;13287-13292
61. Terry R.D., Gonatas N.K., Weiss M. Ultrastructural studies in Alzheimer's presenile dementia. Am. J. Pathol. 44:1964;269-297
62. Thai D.R., Hartig W., Schober R. Diffuse plaques in the molecular layer show intracellular Aβ8-17-immunoreactive deposits in subpial astrocytes. Clin. Neuropathol. 18(5):1999;228-231
63. Tsujiyama Y. Contributions a l'etude histopathologique des plaques seniles. Keio J. Med. 14:1934;1529-1541
64. Uchihara T., Duyckaerts C., He Y., Kobayashi K., Seilhean D., Amouyel P., et al. ApoE immunoreactivity and microglial cells in Alzheimer's disease brain. Neurosci. Lett. 195:1995;5-8
65. Van Groen T., Liu L., Ikonen S., Kadish I. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions. Neuroscience. 119:2003;1185-1197
66. Verbeek M.M., Eikelenboom P., De Waal R.M.W. Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer Disease. J. Neuropathol. Exp. Pathol. 56(7):1997;751-761
67. Wang H.-Y., D'Andrea M.R., Nagele R.G. Cerebellar diffuse amyloid plaques are derived from dendritic Aβ42 accumulations in Purkinje cells. Neurobiol. Aging. 23(2):2002;213-223
68. Wong A., Luth H.J., Deuther-Conrad W., Dukic-Stefanovic S., Gasic-Milenkovic J., Arendt T., et al. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. Brain Res. 920:2001;32-40
69. Wyss-Coray T., McConlogue L., Kindy M., Schmidt A.M., Yan S.D., Stern D.M. Key signaling pathways regulate the biological activities and accumulation of amyloid-β Neurobiol. Aging. 22:2001;967-973
70. Wyss-Coray T., Lin C., Yan F., Yu G.Q., Rohde M., McConlogue L., et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7:2002;612-618
71. Wyss-Coray T., Loike J.D., Brionne T.C., Lu E., Anankov R., Yan F., et al. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 9:2003;453-457
72. Yamaguchi H., Hirai S., Morimatsu M., Shoji M., Harigaya Y. Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropath. 77:1988;113-119
73. Yan Q., Zhang J., Liu H., Babu-Khan S., Vassar R., Biere A.L., et al. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J. Neurosci. 23:2003;7504-7509